Purpose: The use of deep learning to auto-contour organs at risk (OARs) in gynecologic radiation treatment is well established. Yet, there is limited data investigating the prospective use of auto-contouring in clinical practice. In this study, we assess the accuracy and efficiency of auto-contouring OARs for computed tomography-based brachytherapy treatment planning of gynecologic malignancies. Methods and materials: An inhouse contouring tool automatically delineated 5 OARs in gynecologic radiation treatment planning: the bladder, small bowel, sigmoid, rectum, and urethra. Accuracy of each auto-contour was evaluated using a 5-point Likert scale: a score of 5 indicated the contour could be used without edits, while a score of 1 indicated the contour was unusable. During scoring, automated contours were edited and subsequently used for treatment planning. Dice similarity coefficient, mean surface distance, 95% Hausdorff distance, Hausdorff distance, and dosimetric changes between original and edited contours were calculated. Contour approval time and total planning time of a prospective auto-contoured (AC) cohort were compared with times from a retrospective manually contoured (MC) cohort. Results: Thirty AC cases from January 2022 to July 2022 and 31 MC cases from July 2021 to January 2022 were included. The mean (+/- SD) Likert score for each OAR was the following: bladder 4.77 (+/- 0.58), small bowel 3.96 (+/- 0.91), sigmoid colon 3.92 (+/- 0.81), rectum 4.6 (+/- 0.71), and urethra 4.27 (+/- 0.78). No ACs required major edits. All OARs had a mean Dice similarity coefficient > 0.86, mean surface distance < 0.48 mm, 95% Hausdorff distance < 3.2 mm, and Hausdorff distance < 10.32 mm between original and edited contours. There was no significant difference in dose-volume histogram metrics (D2.0 cc/D0.1 cc) between original and edited contours (P values > .05). The average time to plan approval in the AC cohort was 19% less than the MC cohort. (AC vs MC, 117.0 + 18.0 minutes vs 144.9 +/- 64.5 minutes, P = .045). Conclusions: Automated contouring is useful and accurate in clinical practice. Auto-contouring OARs streamlines radiation treatment workflows and decreases time required to design and approve gynecologic brachytherapy plans. (c) 2024 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open accessarticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

The nnU-Net can automatically detect HDR needles with high confidence. Using applicator-specific identification models may improve digitization accuracy. Further evaluation of these tools on larger datasets will confirm the findings of this study.

Purpose This study aimed to explore the relationship between applicator surface dose and 5 mm-depth dose and to optimize both locations simultaneously for three most used cylinder sizes (2.5, 3.0, and 3.5 cm in diameter) in treating patients with endometrial adenocarcinoma. Materials and methods A total of 216 plans were created for each dose level and applicator size. For each dose level, four plans were created with single or double prescription doses. For plans with double prescription doses, the dose constraints were applied to all those points on the surface and 5 mm depth and optimize the two sites simultaneously. Results A dose table between surface and 5 mm depth and its fifth order polynomial mapping functions were established for each applicator size, so any prescribed dose at one site can find the prescription dose on the other site in optimization on both locations. For plans with a 5 mm-depth prescription, the maximum dose on the surface can be reduced from 145% to 133% if the surface prescription dose is also used; for plans with surface dose prescription, the minimum dose and mean dose can be improved by 2% if 5 mm-depth dose prescription is also used in optimization. Conclusion Dose table and their mapping functions between surface prescription dose and their corresponding 5 mm-depth doses were created. A new optimization method that uses two prescription doses on both surface and 5 mm-depth sites was proposed to reduce the hot dose on the surface and improve the cold dose at 5 mm depth.

Purpose For patient comfort and safety, irradiation times should be kept at a minimum while maintaining high treatment quality. In this study of high dose rate (HDR) therapy with a vaginal cylinder, we used the butterfly optimization algorithm (BOA) to simultaneously optimize individual dwell times for precise dose conformity and for the reduction of total dwell time. Material and methods BOA is a population-based, meta-heuristic algorithm that averts local minima by conducting intensive local and global searching based on switching probability. We constructed an objective function (a stimulus intensity function) that consisted of two components. The first one was the root-mean-squared dose error (RMSE) defined as the square root of the sum of squared differences between the prescribed and delivered dose at the constraint points. The second component was weighted total treatment time. Eight previously treated cases were retrospectively reviewed by re-optimizing the clinical treatment plans with BOA. Results Compared to the eight original plans generated with the commercial adaptive volume optimization algorithm (AVOA), the BOA-optimized plans reduced treatment times by 5.4% to 8.9%, corresponding to a time-saving of 13.1 to 47.7 seconds with the activities on the treatment day and saving from 29.3 to 64.6 seconds if treated with an activity of 5 CI. Dose deviations from the prescription were smaller than in the original plans. Conclusion Dose optimizations based on the BOA algorithm yield closer dose conformity in vaginal HDR treatment than AVOA. Incorporating total treatment time into the optimization algorithm reduces the delivery time while having only a small effect on dose conformity.

AbstractPurposeTo evaluate a two‐dimensional diode array for patient‐specific quality assurance of VMAT stereotactic radiosurgery (SRS) plans.MethodsThe diode array, an SRS MapCHECK (SRSMC), was composed of a 77 mm ×77 mm face‐centered array having a spacing of 2.47 mm. Sixty SRS plans were selected from our clinical database, 30 for treatment of a single target and 30 for multiple targets. The target sizes ranged from 2.4 mm to 44.7 mm equivalent diameter (median 8.7 mm). The plans were delivered to the diode array. For multiple target plans, two measurements were obtained at two locations, one corresponding to the largest target and the other to the smallest target. Gamma using a 3%/1 mm criteria and the dose to the center diode were compared with radiochromic film (RCF). Dose to selected regions of the detector electronics was calculated.ResultsThe mean difference between the center diode and RCF was −1.2%. For a threshold of at least 95% of detectors/pixels having gamma < 1 for a 3%/1 mm criteria, SRSMC and RCF gave consistent results for 79 of the 90 measurements. For plans with an arc having a patient support angle of 90° or 270°, the median dose to the electronics was 0.65% of the prescription dose.ConclusionsSRSMC is an efficient tool for accurate patient‐specific quality assurance of VMAT single and multiple target radiosurgery, yielding similar clinical decisions as radiochromic film.

Since Theragenics Corporation (Buford, GA) introduced their I-125 seed model AgX100 in 2010, several studies...

Abstract Purpose To evaluate a scintillator detector for patient‐specific quality assurance of VMAT radiosurgery plans. Methods The detector was comprised of a 1 mm diameter, 1 mm high scintillator coupled to an acrylic optical fiber. Sixty VMAT SRS plans for treatment of single targets having sizes ranging from 3 mm to 30.2 mm equivalent diameter (median 16.3 mm) were selected. The plans were delivered to a 20 cm × 20 cm x 15 cm water equivalent plastic phantom having either the scintillator detector or radiochromic film at the center. Calibration films were obtained for each measurement session. The films were scanned and converted to dose using a 3‐channel technique. Results The mean difference between scintillator and film was ‒0.45% (95% confidence interval ‒0.1% to 0.8%). For target equivalent diameter smaller than the median, the mean difference was 1.1% (95% confidence interval 0.5% to 1.7%). For targets larger than the median, the mean difference was ‒0.2% (95% confidence interval ‒0.7% to 0.1%). Conclusions The scintillator detector response is independent of target size for targets as small as 3 mm and is well‐suited for patient‐specific quality assurance of VMAT SRS plans. Further work is needed to evaluate the accuracy for VMAT plans that treat multiple targets using a single isocenter.

AbstractPurposeTo assess the feasibility of using portal dosimetry (PD) for pre‐treatment quality assurance of single target, flattening filter free (FFF), volumetric arc therapy intracranial radiosurgery plans.MethodsA PD algorithm was created for a 10X FFF beam on a Varian Edge linear accelerator (Varian Inc, Palo Alto, CA, USA). Treatment plans that were previously evaluated with Gafchromic EBT‐XD (Ashland, Bridgewater, NJ, USA) film were measured via PD and analyzed with the ARIA Portal Dosimetry workspace. Absolute dose evaluation for film and PD was done by computing the mean dose in the region receiving greater than or equal to 90% of the max dose and comparing to the mean dose in the same region calculated by the treatment planning system (TPS). Gamma analysis with 10% threshold and 3%/2 mm passing criteria was performed on film and portal images.ResultsThirty‐six PD verification plans were delivered and analyzed. The average PD to TPS dose was 0.989 ± 0.01 while film to TPS dose was 1.026 ± 0.01. All PD plans passed the gamma analysis with 100% of points having gamma <1. Overall, PD to TPS dose agreement was found to be target size dependent. As target size decreases, PD to TPS dose ratio decreased from 1.004 for targets with diameters between 15–31 mm and 0.978 for targets with diameters less than 15 mm.ConclusionThe agreement of PD to TPS mean dose in the high dose region was found to be dependent on target size. Film measurements did not exhibit size dependence. All PD plans passed the 3%/2 mm gamma analysis, but caution should be used when using PD to assess overall dosimetric accuracy of the treatment plan for small targets.

Abstract Purpose To evaluate the accuracy of monitoring intrafraction motion during stereotactic radiotherapy with the optical surface monitoring system. Prior studies showing a false increase in the magnitude of translational offsets at non‐coplanar couch positions prompted the vendor to implement software changes. This study evaluated two software improvements intended to address false offsets. Methods The vendor implemented two software improvements: a volumetric (ACO) rather than planar calibration and, approximately 6 months later, an improved calibration workflow (CIB) designed to better compensate for thermal drift. Offsets relative to the reference position, obtained at table angle 0 following image‐guided setup, were recorded before beam‐on at each table position and at the end of treatment the table returned to 0° for patients receiving SRT. Results Prior to ACO, between ACO and CIB, and after CIB, 223, 155, and 436 fractions were observed respectively. The median magnitude of translational offsets at the end of treatment was similar for all three intervals: 0.29, 0.33, and 0.27 mm. Prior to ACO, the offset magnitude for non‐zero table positions had a median of 0.79 mm and was found to increase with increasing distance from isocenter to the anterior patient surface. After ACO, the median magnitude was 0.74 mm, but the dependence on surface‐to‐isocenter distance was eliminated. After CIB, the median magnitude for non‐zero table positions was reduced to 0.57 mm. Conclusion Ongoing improvements in software and calibration procedures have decreased reporting of false offsets at non‐zero table angles. However, the median magnitude for non‐zero table angles is larger than that observed at the end of treatment, indicating that accuracy remains better when the table is not rotated.

Abstract Purpose To measure dosimetric and spatial accuracy of stereotactic radiosurgery (SRS) delivered to targets as small as the trigeminal nerve (TN) using a standard external beam treatment planning system (TPS) and multileaf collimator‐(MLC) equipped linear accelerator without cones or other special attachments or modifications. Methods Dosimetric performance was assessed by comparing computed dose distributions to film measurements. Comparisons included the γ‐index, beam profiles, isodose lines, maximum dose, and spatial accuracy. Initially, single static 360° arcs of MLC‐shaped fields ranging from 1.6 × 5 to 30 × 30 mm2 were planned and delivered to an in‐house built block phantom having approximate dimensions of a human head. The phantom was equipped with markings that allowed accurate setup using planar kV images. Couch walkout during multiple‐arc treatments was investigated by tracking a ball pointer, initially positioned at cone beam computed tomography (CBCT) isocenter, as the couch was rotated. Tracks were mapped with no load and a 90 kg stack of plastic plates simulating patient treatment. The dosimetric effect of walkout was assessed computationally by comparing test plans that corrected for walkout to plans that neglected walkout. The plans involved nine 160° arcs of 2.4 × 5 mm2 fields applied at six different couch angles. For end‐to‐end tests that included CT simulation, target contouring, planning, and delivery, a cylindrical phantom mimicking a 3 mm lesion was constructed and irradiated with the nine‐arc regimen. The phantom, lacking markings as setup aids was positioned under CBCT guidance by registering its surface and internal structures with CTs from simulation. Radiochromic film passing through the target center was inserted parallel to the coronal and the sagittal plane for assessment of spatial and dosimetric accuracy. Results In the single‐arc block phantom tests computed maximum doses of all field sizes agreed with measurements within 2.4 ± 2.0%. Profile widths at 50% maximum agreed within 0.2 mm. The largest targeting error was 0.33 mm. The γ‐index (3%, 1 mm) averaged over 10 experiments was >1 in only 1% of pixels for field sizes up to 10 × 10 mm2 and rose to 4.4% as field size increased to 20 × 20 mm2. Table walkout was not affected by load. Walkout shifted the target up to 0.6 mm from CBCT isocenter but, according to computations shifted the dose cloud of the nine‐arc plan by only 0.16 mm. Film measurements verified the small dosimetric effect of walkout, allowing walkout to be neglected during planning and treatment. In the end‐to‐end tests average and maximum targeting errors were 0.30 ± 0.10 and 0.43 mm, respectively. Gamma analysis of coronal and sagittal dose distributions based on a 3%/0.3 mm agreement remained <1 at all pixels. To date, more than 50 functional SRS treatments using MLC‐shaped static field arcs have been delivered. Conclusion Stereotactic radiosurgery (SRS) can be planned and delivered on a standard linac without cones or other modifications with better than 0.5 mm spatial and 5% dosimetric accuracy.